| Antigen | A 16-aa peptide (designated NMUR21-P or control peptide) mapping at the extracellular, N-terminal domain or human NMUR2, and a 20 AA peptide (designated NMUR22-P or control peptide) within the cytoplasmic, C-terminal domain of rat NMUR21 were synthesized, coupled to KLH |
| Form | Antigen/blocking Peptide |
| Product Type | Peptide |
| SpCrossreactivity | The 16-aa human NMUR21-P sequence is 85% conserved in mouse and rat NMUR2. No significant sequence homology exist with NMUR1 or Ghrelin receptors or other proteins. Antibody cross-reactivity in various species has not been studied |
| SpeciesReactivity | Human |
| SugApplications | Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization. |